e-ISSN: 2764-9415
Epilepsy is a brain disorder that occurs due to excessive electrical discharges and manifests itself in epileptic seizures. In pregnancy, seizure control can become more difficult due to the organic changes that occur during this period. The antiepileptic drug (AED) regimen used during pregnancy will influence fetal development, resulting in both congenital abnormalities and alterations in child development. The aim of this study was to analyze the potential maternal and fetal complications resulting from epilepsy itself and/or its clinical management during pregnancy. We analyzed 35 medical records and interviewed women with ICD G40.0 to G40.9 who became pregnant between 2005 and 2017. After data collection, statistical analysis was performed using Fisher's exact test and simple statistical analysis with the data obtained. It was concluded that the type of EAF, as well as its regimen with the greatest teratogenic potential, has still been widely used by pregnant women with epilepsy, demonstrating the need to raise awareness for better therapeutic management for these patients.